WHO ICTRP trial
Effect of Anti-streptococcus antibody containing tablet on Streptococcus mutans…
CTRI/2020/02/023667 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2020/02/023667 |
|---|---|
| Public title | Effect of Anti-streptococcus antibody containing tablet on Streptococcus mutans count, causative factor of dental caries. |
| Scientific title | Effect of commercially available anti-streptococcus IgY containing tablet on Streptococcus mutans count in caries active children: In vivo study |
| Primary sponsor | Inzpera Healthsciences Ltd A Subsidiary of Tata Industries Limited |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Post Marketing Surveillance |
| Countries | India |
| Conditions | Health Condition 1: A488- Other specified bacterial diseases |
| Interventions | Intervention1: NoDecay Chew able Tablet: The tablet contains Egg Yolk protein powder (Delipidated), Mannitol, Maltitol, Xylitol, cross carmellose sodium, peppermint, orange flavour, microcrystalline cellulose, steviol glycoside, magnesium… |
| Registration date | Feb 28, 2020 |
| Target size | 60 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: